How to Get Soliris (eculizumab) Covered by Cigna in Ohio: Complete Coding, Prior Authorization, and Appeals Guide
Answer Box: Get Soliris (eculizumab) Covered by Cigna in Ohio
Fastest Path to Approval: Submit complete prior authorization with proper coding (HCPCS J1300, correct NDC 25682-0001-01, diagnosis-specific ICD-10), meningococcal vaccination records, and REMS enrollment documentation. If denied, file internal appeal within 180 days, then request Ohio external review through Independent Review Organization (IRO). Start today: Download Cigna's Soliris PA form and gather vaccination records.
Table of Contents
- Coding Basics: Medical vs. Pharmacy Benefit
- ICD-10 Mapping for Soliris Indications
- Product Coding: HCPCS, NDC, and Units
- Clean Prior Authorization Anatomy
- Frequent Coding Pitfalls
- Verification with Cigna Resources
- Appeals Playbook for Ohio
- Quick Audit Checklist
- FAQ
Coding Basics: Medical vs. Pharmacy Benefit
Soliris (eculizumab) is almost always billed as a medical benefit because it requires IV infusion by healthcare providers. Understanding this distinction is crucial for proper coding and reimbursement.
Medical Benefit Path (Standard):
- Uses HCPCS J-codes for billing
- Requires site-of-care documentation
- Includes administration costs
- Subject to medical necessity reviews
Pharmacy Benefit Path (Rare):
- Limited to specialty pharmacies
- Uses NDC-only billing
- Requires different prior authorization forms
Note: Cigna typically processes Soliris through their medical benefit with Express Scripts managing specialty drug reviews.
ICD-10 Mapping for Soliris Indications
Proper diagnosis coding is essential for Soliris approval. Each indication requires specific diagnostic confirmation and documentation.
| Indication | Primary ICD-10 Code | Required Documentation |
|---|---|---|
| Paroxysmal Nocturnal Hemoglobinuria (PNH) | D59.5 (PNH) or related hemolysis codes | Flow cytometry (CD55/CD59 deficiency), FLAER test |
| Atypical Hemolytic Uremic Syndrome (aHUS) | D59.3 (Non-autoimmune hemolytic anemia) | Genetic/complement testing, exclusion of other TMA |
| Generalized Myasthenia Gravis | G70.00 (without exacerbation) or G70.01 (with exacerbation) | AChR+ antibodies, MG-ADL score, specialist confirmation |
| NMOSD | Use optic neuritis/myelitis codes as appropriate | AQP4+ antibodies, MRI findings, neurologist evaluation |
Documentation Words That Support Coding:
- "Confirmed by flow cytometry"
- "Genetic testing positive for complement pathway mutation"
- "Failed conventional therapy"
- "Specialist-confirmed diagnosis"
Product Coding: HCPCS, NDC, and Units
HCPCS J-Code: J1300 (Injection, eculizumab, 10 mg)
- Each unit = 10 mg of eculizumab
- Calculate units: Total dose ÷ 10 mg
NDC Code: 25682-0001-01 (300 mg/30 mL vial)
- Use 11-digit HIPAA-compliant format
- NDC units = total mg administered (not vials)
Units Calculation Example:
- Patient receives 1200 mg dose
- HCPCS units: 1200 ÷ 10 = 120 units of J1300
- NDC units: 1200 mg (4 vials × 300 mg each)
Required Modifiers:
- -RE: REMS compliance (some payers require)
- Site-specific modifiers as needed
Clean Prior Authorization Anatomy
A complete Cigna prior authorization for Soliris must include:
Essential Elements Checklist:
- Patient demographics and Cigna ID
- Prescriber NPI and REMS enrollment proof
- Diagnosis with ICD-10 code
- Meningococcal vaccination records (≥2 weeks prior)
- Medical necessity statement
- Prior therapy documentation
- Dosing rationale and monitoring plan
- Site-of-care justification
Medical Necessity Statement Template:
Patient has [diagnosis] confirmed by [specific test]. Prior treatments
including [list medications] were discontinued due to [lack of efficacy/
adverse events]. Soliris is medically necessary as [clinical rationale].
Patient has completed required meningococcal vaccination on [date].
Frequent Coding Pitfalls
| Common Error | Impact | Fix |
|---|---|---|
| Using vial count instead of mg for NDC units | Claim rejection | Always use total mg administered |
| Missing vaccination documentation | Automatic denial | Attach dated vaccination records |
| Incorrect J1300 unit calculation | Underpayment or rejection | Double-check: total mg ÷ 10 |
| Wrong ICD-10 for indication | Medical necessity denial | Use indication-specific codes |
| Missing REMS enrollment | PA denial | Verify prescriber in REMS database |
Unit Conversion Errors: The most common mistake is calculating J1300 units incorrectly. Remember: 1 unit of J1300 = 10 mg eculizumab, not 1 mg.
Verification with Cigna Resources
Before submitting your prior authorization:
- Check Current Forms: Download the latest Cigna Soliris PA form
- Verify Formulary Status: Review Cigna's formulary for tier placement
- Confirm Submission Method:
- Fax: 855-840-1678
- Online: CoverMyMeds portal
- EHR: SureScripts integration
Tip: Call Cigna provider services at 1-800-88CIGNA to verify current submission requirements before sending your PA.
Appeals Playbook for Ohio
If your Soliris prior authorization is denied, Ohio provides multiple appeal levels:
Internal Appeals (Cigna)
Timeline: 180 days from denial date Process:
- Submit written appeal with additional documentation
- Standard review: 15 days
- Expedited review: 72 hours (if urgent)
External Review (Ohio Department of Insurance)
Timeline: 180 days after final internal denial Process:
- Request external review through Ohio Department of Insurance
- Independent Review Organization (IRO) assigned
- Decision timeline:
- Standard: 30 days
- Expedited: 72 hours
- IRO decision is binding on Cigna
Ohio External Review Statistics: Approximately 35-38% of external reviews result in reversal of insurer denials.
Appeal Template for Soliris
[Date]
Cigna Appeals Department
Re: Prior Authorization Appeal - Soliris (eculizumab)
Patient: [Name, DOB, Cigna ID]
I am appealing the denial of Soliris (eculizumab) for my patient with
[diagnosis]. The denial was based on [reason from denial letter].
Medical Necessity Justification:
- Patient meets FDA-approved criteria for [indication]
- Required meningococcal vaccination completed [date]
- Prior therapies failed: [list with dates and reasons]
- Soliris is the only appropriate treatment due to [clinical rationale]
Attached documentation includes:
- Updated clinical notes
- Vaccination records
- Lab results confirming diagnosis
- Treatment history
Expedited review requested due to [urgent medical need].
[Provider signature and credentials]
Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals for complex medications like Soliris. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals with the right clinical evidence and procedural requirements for each payer's specific workflow.
Quick Audit Checklist
Before submitting any Soliris claim or prior authorization:
Coding Verification:
- J1300 units calculated correctly (total mg ÷ 10)
- NDC format is 11-digit HIPAA compliant
- ICD-10 matches confirmed diagnosis
- Required modifiers included
Documentation Complete:
- Meningococcal vaccination proof (dated ≥2 weeks prior)
- REMS enrollment verified
- Medical necessity clearly stated
- Prior therapy failures documented
- Specialist confirmation attached
Submission Requirements:
- Current Cigna form used
- All required fields completed
- Supporting documents attached
- Submission method verified
FAQ
How long does Cigna prior authorization take for Soliris in Ohio? Standard requests: 15 days. Expedited requests: 72 hours. Mark urgent cases for faster review.
What if Soliris is non-formulary on my Cigna plan? Request a formulary exception through Cigna's exception process. Include clinical rationale for why covered alternatives aren't appropriate.
Can I request an expedited appeal in Ohio? Yes. Both Cigna internal appeals and Ohio external reviews offer expedited timelines (72 hours) if delay would jeopardize your health.
What happens if I miss the 180-day appeal deadline? You lose the right to internal and external appeals for that denial. File appeals promptly after receiving denial letters.
Does step therapy apply to Soliris? Cigna may require trials of other medications first. Request step therapy override with documentation of prior failures or contraindications.
How do I contact Ohio Department of Insurance for help? Call 1-800-686-1526 for consumer assistance with health coverage appeals and external review questions.
This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions vary by plan. For personalized assistance with complex prior authorizations and appeals, Counterforce Health helps patients and clinicians navigate insurance denials with evidence-based appeals tailored to each payer's requirements.
Sources & Further Reading
- Cigna Soliris Prior Authorization Form (PDF)
- Ohio Department of Insurance External Review Process
- Cigna Coverage Policy for Eculizumab
- Soliris Coding and Billing Guide
- Ohio External Review Statistics
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.